1.
Eskazan AE, Soysal T. The tolerability issue of generic imatinib in patients with chronic myeloid leukemia (Comment on Adi J. Klil-Drori et al., Haematologica 2019;104(7):e293). Haematologica [Internet]. 2019Jun.30 [cited 2026Nov.11];104(7):e330-e330. Available from: https://haematologica.org/article/view/8993